Nutriband (NTRB) Stock Forecast: StockMap's 2-Week Call
NTRB stock forecast: StockMap's model makes no two-week call on Nutriband after the Nov 19 close: its evidence is split, 4 reasons for and 11 against. Right in 1 of 4 two-week windows on NTRB since Aug 21; by chance, a call on the same dates was right 69% of the time.
Nutriband last closed at $5.00, +3.73% on the session.
Against the IVW growth benchmark the position is +6.06% over the forecast window.
Nutriband's market cap is $60.78M as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -18 (too close to call).
Where NTRB sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 4 bullish and 11 bearish.
Agreement across those insights is 73%.
28 daily calls for NTRB so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Nutriband in the 10th percentile on return on equity, where 100 is best.
Nutriband is classified under Health Care / Pharmaceuticals.
StockMap tracks Nutriband as the 107th largest of the 153 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.
Across that group the current two-week reads are 80 Moderate Underperform, 44 Neutral and 29 Strong Underperform.
On that composite Nutriband ranks 42nd of 153 in the group, against a group median of -0.36.